News | Catheters | April 03, 2024

FDA Announces Teleflex and Arrow International Recall of ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits for Increased Resistance That May Lead to Vessel Injuries, Narrowing, or Blockage

 

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death

April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are recalling the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits after receiving reports of increased resistance in the guidewire handle and chamber during use. This issue may cause serious injury, including injury to blood vessel walls, narrowing of the blood vessels (vasospasm), artery blockage (embolism), or death.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death.

Recalled Product 

  • Product Name: ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits
  • Product Codes: See Recall Database Entry 
  • Devices Recalled in the U.S.: 334,995 
  • Dates Distributed: December 1, 2021 to January 27, 2024
  • Date Initiated by Firm: February 12, 2024

Device Use

The ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits allow health care providers access to a patient’s peripheral arterial circulation or other small vessels. 

Reason for Recall  

Teleflex, and their subsidiary Arrow International, are recalling the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits after receiving reports of increased resistance in the guidewire handle and chamber during use. 

This issue may cause serious injury, including injury to blood vessel walls, narrowing of the blood vessels (vasospasm), artery blockage (embolism), or death. 
 
Teleflex/Arrow International reports 194 complaints. A total of 10 injuries, and one death have been reported related to this issue. 

Who May Be Affected 

  • People who receive care with the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits.

What to Do 

On February 12, 2024, Teleflex and Arrow International sent an Urgent Medical Device Recall letter to customers that included the following recommended actions:

For Medical Facilities

  • Immediately:
    • Check inventory for product within the scope of this recall. 
    • Stop using and distributing affected product.
    • Quarantine affected product.
  • Mark the applicable checkbox (affected product or no affected product) on the acknowledgement form included with the letter. Fax the form to 1-855-419-8507 to Attn: Customer Service or email the form to [email protected]
    • If you have affected product, a customer service representative will contact you with a Return Goods Authorization (RGA) number and will provide instructions for the return of affected products to Teleflex. Teleflex (or the local dealer) will issue a credit note upon receipt of the returned affected product.
    • Ensure you only list batch numbers in scope of the recall notice when completing the form. 

For Distributors

  • Provide a copy of the Urgent Medical Device Recall letter to all customers who have received impacted product. Each customer must complete the acknowledgement form and return it to the distributor. 
  • Immediately:
    • Check inventory for product within the scope of this recall. 
    • Stop using and distributing affected product.
    • Quarantine affected product.
    • Return all product in scope.
  • Confirm to Teleflex that field activities outlined have been completed. 
  • After completing actions, forward the completed acknowledgement form to [email protected].
    • Ensure you only list batch numbers in scope of the recall notice when completing the form. 
  • If product was distributed outside of the country, notify Teleflex Customer Service.

Contact Information 

Customers with questions should contact Teleflex and Arrow International Customer Service: 
Phone: 1-866-396-2111
FAX: 1-855-419-8507
Email: [email protected] 

Additional Resources 

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.


Related Content

News | FDA

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its ...

Home July 02, 2024
Home
News | FDA

June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary ...

Home June 18, 2024
Home
News | FDA

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting ...

Home June 17, 2024
Home
News | FDA

June 13, 2024 — Xeltis, a leading developer of transformative implants that enable the natural creation of living and ...

Home June 13, 2024
Home
News | FDA

June 3, 2024 — Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea ...

Home June 03, 2024
Home
News | FDA

May 17, 2024 — Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has ...

Home May 17, 2024
Home
News | FDA

May 15, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling the HeartMate 3 LVAS by ...

Home May 15, 2024
Home
News | FDA

May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...

Home May 08, 2024
Home
News | FDA

May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally ...

Home May 08, 2024
Home
News | FDA

May 7, 2024 — RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology ...

Home May 07, 2024
Home
Subscribe Now